Emergency authorization for COVID-19 vaccine asked by Johnson & Johnson

US health regulators have been asked by Johnson & Johnson to authorize its single-dose COVID-19 vaccine for emergency use. The vaccine has had a rate of 66 percent of preventing infections in its large global trials. The supply of COVID-19 vaccines in the United States could be boosted with the single dose vaccine and could help increase the rate of the vaccination process.

Emergency authorization for COVID-19 vaccine asked by Johnson & Johnson

Co-founder of Vans shoes passed away at his 90

NY hedge fund founder sentenced to prison in Neiman Marcus fraud

Jewelry maker Pandora will no longer use mined diamonds

Dogecoin rally is a ’middle finger’ to the financial system: Mike Novogratz

US to back waivers for COVID-19 vaccine patents

Bezos sells nearly $2 billion worth of Amazon shares

Google relaxes remote work plan

World leaders are ready to waive IP rights of Covid-19 vaccines

Sotheby’s to accept bitcoin, ethereum for Banksy auction

Coca-Cola pauses aggressive diversity plan after chief lawyer resigns

Verizon sells Yahoo and AOL as part of $5 billion deal

Tik Tok appoints new CEO, Shou Zi Chew after previous CEO resigned

Ethereum trades over $3,000 for the first time

Buffett warns investors not to gamble on stocks

Ever Given’s Japanese owner asks cargo owners to share Suez Canal compensation

Gates started an organization to provide enough vaccines to people in need

Biden’s 100-day stock market run is the best for a US President since the 1950s

Tesla’s misses Q1 revenue target, bottomline aided by bitcoin profit

Turkish crypto exchange CEO flees with reported $2 billion

Biden to propose capital gains tax of 39.6%, reports say

Tesla’s solar panels to be sold only with Powerwall

Daily Mail owner sues Google over search results

Amazon to let Whole Foods shoppers pay with a swipe of their palm

Credit Suisse had more than $20B exposure to Archegos investments: WSJ

Foxconn’s Wisconsin deal shrinks significantly